Cellosaurus KM641 (CVCL_D3P7)
| Cell line name | KM641 |
|---|---|
| Synonyms | KM-641 |
| Accession | CVCL_D3P7 |
| Resource Identification Initiative | To cite this cell line use: KM641 (RRID:CVCL_D3P7) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3116. Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the chimeric (mouse/human) ecromeximab (KM871) therapeutic antibody developed for the treatment of malignant melanoma. Monoclonal antibody isotype: IgG3, kappa. Monoclonal antibody target: ChEBI; CHEBI:89636; Ganglioside GD3. |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Hierarchy | Parent: CVCL_3412 (P3X63Ag8U.1) |
| Category | Hybridoma |
| Publications | Patent=EP0493686B1 PubMed=8439988; DOI=10.1007/BF01740908; PMCID=PMC11038899 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q127382552 |
| Entry history | |
| Entry creation | 30-Jan-2024 |
| Last entry update | 10-Sep-2024 |
| Version number | 2 |